Thailand for the country. Mahidol University, under the leadership of Prof. Dr. Hummel history as no developer. vaccines for dengue infection is a type of light scribe is the first and the. Assoc. Prof. Dr.. suthi yoksan successors spirit with experience in the development of a vaccine that has a long history and expertise of Dr.. suthi recognized international sides from dengue, in conjunction with the ability of genetic engineering, Prof. Dr.. Mithun entitled treasures from the Faculty of medicine, Chiang Mai University, with the support of the budget, including the management and research of push science and technology development agency (nstda), national. Vaccine induces hybrids fuel type, genetic engineering is the light scribe 1 series, but which the company bio-NET Asia. Thailand has asked the people's company to develop, so that the citizens will have the vaccine in Thailand. Prevention of dengue continue to use in the near future.
การแปล กรุณารอสักครู่..